HRP20030024A2 - Method for the treatment of climacteric disorders in women or after the menopause - Google Patents

Method for the treatment of climacteric disorders in women or after the menopause

Info

Publication number
HRP20030024A2
HRP20030024A2 HR20030024A HRP20030024A HRP20030024A2 HR P20030024 A2 HRP20030024 A2 HR P20030024A2 HR 20030024 A HR20030024 A HR 20030024A HR P20030024 A HRP20030024 A HR P20030024A HR P20030024 A2 HRP20030024 A2 HR P20030024A2
Authority
HR
Croatia
Prior art keywords
menopause
women
treatment
climacteric disorders
climacteric
Prior art date
Application number
HR20030024A
Other languages
English (en)
Croatian (hr)
Inventor
Halonen Kaija
Kangas Lauri
W. Degregorio Michael
Original Assignee
Hormos Medical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24504996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030024(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hormos Medical Corporation filed Critical Hormos Medical Corporation
Publication of HRP20030024A2 publication Critical patent/HRP20030024A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20030024A 2000-07-21 2003-01-17 Method for the treatment of climacteric disorders in women or after the menopause HRP20030024A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/625,199 US6245819B1 (en) 2000-07-21 2000-07-21 Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
PCT/FI2001/000414 WO2002007718A1 (en) 2000-07-21 2001-05-02 Method for the treatment of climacteric disorders in women during or after the menopause

Publications (1)

Publication Number Publication Date
HRP20030024A2 true HRP20030024A2 (en) 2006-12-31

Family

ID=24504996

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030024A HRP20030024A2 (en) 2000-07-21 2003-01-17 Method for the treatment of climacteric disorders in women or after the menopause

Country Status (31)

Country Link
US (5) US6245819B1 (es)
EP (1) EP1305014B1 (es)
JP (2) JP5575351B2 (es)
KR (1) KR100880564B1 (es)
CN (1) CN1287775C (es)
AT (1) ATE300289T1 (es)
AU (2) AU5844901A (es)
BG (1) BG65943B1 (es)
BR (1) BR0112659A (es)
CA (1) CA2416480C (es)
CY (1) CY1105370T1 (es)
CZ (1) CZ299439B6 (es)
DE (1) DE60112301T2 (es)
DK (1) DK1305014T3 (es)
EE (1) EE05344B1 (es)
ES (1) ES2241819T3 (es)
HK (1) HK1056694A1 (es)
HR (1) HRP20030024A2 (es)
HU (1) HU229361B1 (es)
IL (1) IL153823A (es)
MX (1) MXPA03000378A (es)
NO (1) NO329954B1 (es)
NZ (1) NZ524181A (es)
PL (1) PL202654B1 (es)
PT (1) PT1305014E (es)
RU (1) RU2268035C2 (es)
SI (1) SI1305014T1 (es)
SK (1) SK287096B6 (es)
UA (1) UA74386C2 (es)
WO (1) WO2002007718A1 (es)
ZA (1) ZA200300342B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
AU2001261244B2 (en) * 2000-05-09 2006-08-03 Nitromed, Inc. Infrared thermography and methods of use
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
WO2003103649A1 (en) * 2002-06-06 2003-12-18 Hormos Medical Corporation Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
JP2006515276A (ja) * 2002-10-22 2006-05-25 オスコテック株式会社 骨粗鬆症の予防及び治療効果を有するフラン誘導体並びにこれを含む薬学的組成物
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US20050187302A1 (en) * 2004-02-23 2005-08-25 Hormos Medical Corporation Method for treatment or prevention of osteoporosis in individuals with high bone turnover
AU2005237274B2 (en) * 2004-05-04 2011-02-17 Hormos Medical Ltd Novel oral formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
KR100734942B1 (ko) 2007-01-02 2007-07-03 김재현 여성 갱년기 증후군에 유효한 건강기능식품 조성물
SI2121553T1 (sl) 2007-02-14 2012-11-30 Hormos Medical Ltd Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
US7504530B2 (en) * 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
RU2535112C2 (ru) * 2012-09-19 2014-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия министерства здравоохранения и социального развития" Способ лечения климактерических и урогенитальных расстройств у женщин в постменопаузе на фоне гипотириоза
US9321712B2 (en) 2012-10-19 2016-04-26 Fermion Oy Process for the preparation of ospemifene
ES2960344T3 (es) 2015-03-10 2024-03-04 Shionogi Inc Dispersiones sólidas que comprenden ospemifeno
WO2016149675A1 (en) 2015-03-19 2016-09-22 Epstein Wendy Anne Compounds and forms of treatment for female sexual disorders
RU2636619C1 (ru) * 2017-02-20 2017-11-24 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения вагинальной атрофии у женщин в постменопаузе с учетом состояния эпителия и микробиоценоза влагалища

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352699A (en) 1992-04-30 1994-10-04 University Of Massachusetts Medical Center Use of retinioc acid to treat vaginal atrophy
US5461064A (en) * 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
GB9418067D0 (en) * 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
US5747059A (en) 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
GB9604577D0 (en) * 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent
CO5271697A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
PL357163A1 (en) 2000-01-28 2004-07-26 Endorecherche, Inc. Selective estrogen receptor modulators in combination with estrogens
US20010034340A1 (en) 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
PL359506A1 (en) 2004-08-23
NO20030273D0 (no) 2003-01-20
SI1305014T1 (sl) 2005-12-31
CY1105370T1 (el) 2010-04-28
PL202654B1 (pl) 2009-07-31
CN1287775C (zh) 2006-12-06
EE05344B1 (et) 2010-10-15
NO20030273L (no) 2003-01-20
RU2268035C2 (ru) 2006-01-20
US20100280131A1 (en) 2010-11-04
HK1056694A1 (en) 2004-02-27
NZ524181A (en) 2003-07-25
AU5844901A (en) 2002-02-05
US9566252B2 (en) 2017-02-14
ZA200300342B (en) 2004-02-13
JP2004504345A (ja) 2004-02-12
US6984665B2 (en) 2006-01-10
KR100880564B1 (ko) 2009-01-30
ES2241819T3 (es) 2005-11-01
HUP0301791A3 (en) 2008-01-28
WO2002007718A8 (en) 2002-11-14
DE60112301T2 (de) 2006-05-24
SK16072002A3 (sk) 2003-06-03
MXPA03000378A (es) 2003-09-22
HUP0301791A2 (hu) 2003-12-29
HU229361B1 (en) 2013-11-28
US20140142195A1 (en) 2014-05-22
EP1305014A1 (en) 2003-05-02
DK1305014T3 (da) 2005-08-22
KR20030048378A (ko) 2003-06-19
BG107472A (bg) 2003-11-28
JP5575351B2 (ja) 2014-08-20
CA2416480A1 (en) 2002-01-31
WO2002007718A1 (en) 2002-01-31
BR0112659A (pt) 2003-06-24
US20050272825A1 (en) 2005-12-08
IL153823A0 (en) 2003-07-31
EP1305014B1 (en) 2005-07-27
DE60112301D1 (de) 2005-09-01
CA2416480C (en) 2009-12-08
EE200300031A (et) 2004-10-15
CN1446085A (zh) 2003-10-01
US6245819B1 (en) 2001-06-12
JP5629746B2 (ja) 2014-11-26
AU2001258449B2 (en) 2004-07-29
NO329954B1 (no) 2011-01-31
CZ299439B6 (cs) 2008-07-30
US20030036566A1 (en) 2003-02-20
BG65943B1 (bg) 2010-06-30
SK287096B6 (sk) 2009-12-07
ATE300289T1 (de) 2005-08-15
UA74386C2 (uk) 2005-12-15
CZ200326A3 (cs) 2003-05-14
JP2013060445A (ja) 2013-04-04
PT1305014E (pt) 2005-09-30
IL153823A (en) 2008-03-20

Similar Documents

Publication Publication Date Title
HRP20030024A2 (en) Method for the treatment of climacteric disorders in women or after the menopause
RU2003105159A (ru) Способ лечения климактерических расстройств у женщин во время или после менопаузы
TW200505900A (en) Muscarinic agonists
EA200201000A1 (ru) Гормон-заместительная терапия
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
PE20010924A1 (es) Compuestos inhibidores de fosfodiesterasa utiles para el tratamiento de la disfuncion sexual femenina
HK1091418A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
NZ517039A (en) Intravaginal clindamycin ovule composition, where the clindamycin is dispersed in a hard fat suppository base
EA199700282A1 (ru) Азатиоприновые композиции для введения в толстую кишку
DE69912422D1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
GR3035389T3 (en) Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour
HRP20041150A2 (en) Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v
MXPA02007454A (es) Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor.
Neaupane et al. Vaginal biopsy, pregnancy detection and induction of farrowing in crossbred sows
TH51782A (th) การใช้ตัวยับยั้ง pde v
ECSP003771A (es) Metodo para prevenir la diarrea

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070423

Year of fee payment: 7

AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused